ARCHIVES

Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 20 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

Compliance Grants Awarded, Contract Pending On Differences In Black/White Survival

November 19, 1982

New International Policy On Clinical Trials Is Needed, Veronesi Says

October 21, 1983

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980

NCI Plans To Recomplete CCOP; Future Direction To Be Discuss At DCPC Board, NCAB Meetings

January 17, 1986

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995